OBJECTIVE: To identify an evidence-based minimum physical activity threshold to predict improved or sustained high function for adults with lower-extremity joint symptoms. METHODS: Prospective multisite data from 1,629 adults, age ≥49 years with symptomatic lower-extremity joint pain/aching/stiffness, participating in the Osteoarthritis Initiative accelerometer monitoring substudy were clinically assessed 2 years apart. Improved/high function in 2-year gait speed and patient-reported outcomes (PROs) were based on improving or remaining in the best (i.e., maintaining high) function quintile compared to baseline status. Optimal thresholds predicting improved/high function were investigated using classification trees for the legacy federal guideline metric requiring 150 minutes/week of moderate-vigorous (MV) activity in bouts lasting 10 minutes or more (MV-bout) and other metrics (total MV, sedentary, light intensity activity, nonsedentary minutes/week). RESULTS: Optimal thresholds based on total MV minutes/week predicted improved/high function outcomes more strongly than the legacy or other investigated metrics. Meeting the 45 total MV minutes/week threshold had increased relative risk (RR) for improved/high function (gait speed RR 1.8, 95% confidence interval [95% CI] 1.6, 2.1 and PRO physical function RR 1.4, 95% CI 1.3, 1.6) compared to less active adults. Thresholds were consistent across sex, body mass index, knee osteoarthritis status, and age. CONCLUSION: These results supported a physical activity minimum threshold of 45 total MV minutes/week to promote improved or sustained high function for adults with lower-extremity joint symptoms. This evidence-based threshold is less rigorous than federal guidelines (≥150 MV-bout minutes/week) and provides an intermediate goal towards the federal guideline for adults with lower-extremity symptoms.
OBJECTIVE: To identify an evidence-based minimum physical activity threshold to predict improved or sustained high function for adults with lower-extremity joint symptoms. METHODS: Prospective multisite data from 1,629 adults, age ≥49 years with symptomatic lower-extremity joint pain/aching/stiffness, participating in the Osteoarthritis Initiative accelerometer monitoring substudy were clinically assessed 2 years apart. Improved/high function in 2-year gait speed and patient-reported outcomes (PROs) were based on improving or remaining in the best (i.e., maintaining high) function quintile compared to baseline status. Optimal thresholds predicting improved/high function were investigated using classification trees for the legacy federal guideline metric requiring 150 minutes/week of moderate-vigorous (MV) activity in bouts lasting 10 minutes or more (MV-bout) and other metrics (total MV, sedentary, light intensity activity, nonsedentary minutes/week). RESULTS: Optimal thresholds based on total MV minutes/week predicted improved/high function outcomes more strongly than the legacy or other investigated metrics. Meeting the 45 total MV minutes/week threshold had increased relative risk (RR) for improved/high function (gait speed RR 1.8, 95% confidence interval [95% CI] 1.6, 2.1 and PRO physical function RR 1.4, 95% CI 1.3, 1.6) compared to less active adults. Thresholds were consistent across sex, body mass index, knee osteoarthritis status, and age. CONCLUSION: These results supported a physical activity minimum threshold of 45 total MV minutes/week to promote improved or sustained high function for adults with lower-extremity joint symptoms. This evidence-based threshold is less rigorous than federal guidelines (≥150 MV-bout minutes/week) and provides an intermediate goal towards the federal guideline for adults with lower-extremity symptoms.
Authors: Darren Er Warburton; Sarah Charlesworth; Adam Ivey; Lindsay Nettlefold; Shannon Sd Bredin Journal: Int J Behav Nutr Phys Act Date: 2010-05-11 Impact factor: 6.457
Authors: William L Haskell; I-Min Lee; Russell R Pate; Kenneth E Powell; Steven N Blair; Barry A Franklin; Caroline A Macera; Gregory W Heath; Paul D Thompson; Adrian Bauman Journal: Med Sci Sports Exerc Date: 2007-08 Impact factor: 5.411
Authors: G Abellan van Kan; Y Rolland; S Andrieu; J Bauer; O Beauchet; M Bonnefoy; M Cesari; L M Donini; S Gillette Guyonnet; M Inzitari; F Nourhashemi; G Onder; P Ritz; A Salva; M Visser; B Vellas Journal: J Nutr Health Aging Date: 2009-12 Impact factor: 4.075
Authors: Richard P Troiano; David Berrigan; Kevin W Dodd; Louise C Mâsse; Timothy Tilert; Margaret McDowell Journal: Med Sci Sports Exerc Date: 2008-01 Impact factor: 5.411
Authors: Edward H Ip; Timothy Church; Sarah A Marshall; Qiang Zhang; Anthony P Marsh; Jack Guralnik; Abby C King; W Jack Rejeski Journal: J Gerontol A Biol Sci Med Sci Date: 2012-09-17 Impact factor: 6.053
Authors: Prakash Jayabalan; Masha Kocherginsky; Alison H Chang; Gerald W Rouleau; Kimberly L Koloms; Jungwha Lee; Dorothy Dunlop; Rowland W Chang; Leena Sharma Journal: Arthritis Care Res (Hoboken) Date: 2019-02 Impact factor: 4.794
Authors: Megan Huisingh-Scheetz; Kristen Wroblewski; Masha Kocherginsky; Elbert Huang; William Dale; Linda Waite; L Philip Schumm Journal: J Gerontol A Biol Sci Med Sci Date: 2018-04-17 Impact factor: 6.053
Authors: Virginia B Kraus; Kyle Sprow; Kenneth E Powell; David Buchner; Bonny Bloodgood; Katrina Piercy; Stephanie M George; William E Kraus Journal: Med Sci Sports Exerc Date: 2019-06 Impact factor: 5.411
Authors: Dorothy D Dunlop; Jing Song; Jennifer M Hootman; Michael C Nevitt; Pamela A Semanik; Jungwha Lee; Leena Sharma; Charles B Eaton; Marc C Hochberg; Rebecca D Jackson; C Kent Kwoh; Rowland W Chang Journal: Am J Prev Med Date: 2019-03-20 Impact factor: 5.043
Authors: Jin Qin; Kamil E Barbour; Michael C Nevitt; Charles G Helmick; Jennifer M Hootman; Louise B Murphy; Jane A Cauley; Dorothy D Dunlop Journal: Med Sci Sports Exerc Date: 2018-02 Impact factor: 5.411
Authors: Elizabeth A Schlenk; G Kelley Fitzgerald; Joan C Rogers; C Kent Kwoh; Susan M Sereika Journal: J Aging Phys Act Date: 2020-09-04 Impact factor: 1.961
Authors: Sandra H Soto; Leigh F Callahan; Stephanie Bahorski; Mary Altpeter; Derek P Hales; Ashley Phillips; Dana Carthron; Christine Rini Journal: Int J Behav Med Date: 2019-10
Authors: Hiral Master; Louise M Thoma; Dorothy D Dunlop; Meredith B Christiansen; Dana Voinier; Daniel K White Journal: J Rheumatol Date: 2021-02-01 Impact factor: 5.346